Roffman Miller Associates’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-5,346
| Closed | -$273K | – | 100 |
|
|
2020
Q2 | $273K | Buy |
+5,346
| New | +$273K | 0.03% | 124 |
|
|
2019
Q3 | – | Sell |
-4,935
| Closed | -$247K | – | 94 |
|
|
2019
Q2 | $247K | Buy |
4,935
+1,041
| +27% | +$52.1K | 0.03% | 82 |
|
|
2019
Q1 | $204K | Buy |
+3,894
| New | +$204K | 0.02% | 80 |
|
|
2018
Q4 | – | Sell |
-4,542
| Closed | -$228K | – | 77 |
|
|
2018
Q3 | $228K | Hold |
4,542
| – | – | 0.03% | 81 |
|
|
2018
Q2 | $229K | Buy |
4,542
+2
| +0% | +$101 | 0.03% | 62 |
|
|
2018
Q1 | $222K | Sell |
4,540
-606
| -12% | -$29.6K | 0.03% | 62 |
|
|
2017
Q4 | $228K | Sell |
5,146
-90
| -2% | -$3.99K | 0.03% | 62 |
|
|
2017
Q3 | $266K | Sell |
5,236
-499
| -9% | -$25.4K | 0.04% | 62 |
|
|
2017
Q2 | $309K | Sell |
5,735
-1,431
| -20% | -$77.1K | 0.04% | 62 |
|
|
2017
Q1 | $378K | Buy |
7,166
+1,736
| +32% | +$91.6K | 0.05% | 60 |
|
|
2016
Q4 | $261K | Sell |
5,430
-1,772
| -25% | -$85.2K | 0.04% | 61 |
|
|
2016
Q3 | $388K | Sell |
7,202
-8
| -0.1% | -$431 | 0.06% | 59 |
|
|
2016
Q2 | $391K | Buy |
7,210
+60
| +0.8% | +$3.25K | 0.06% | 61 |
|
|
2016
Q1 | $362K | Buy |
7,150
+1,531
| +27% | +$77.5K | 0.06% | 61 |
|
|
2015
Q4 | $283K | Sell |
5,619
-269
| -5% | -$13.5K | 0.05% | 61 |
|
|
2015
Q3 | $283K | Buy |
5,888
+672
| +13% | +$32.3K | 0.06% | 62 |
|
|
2015
Q2 | $272K | Buy |
5,216
+2
| +0% | +$104 | 0.05% | 62 |
|
|
2015
Q1 | $301K | Hold |
5,214
| – | – | 0.06% | 61 |
|
|
2014
Q4 | $279K | Buy |
5,214
+214
| +4% | +$11.5K | 0.05% | 62 |
|
|
2014
Q3 | $287K | Buy |
5,000
+1
| +0% | +$57 | 0.06% | 63 |
|
|
2014
Q2 | $334K | Sell |
4,999
-2,683
| -35% | -$179K | 0.07% | 62 |
|
|
2014
Q1 | $513K | Sell |
7,682
-6,047
| -44% | -$404K | 0.11% | 61 |
|
|
2013
Q4 | $916K | Sell |
13,729
-77,813
| -85% | -$5.19M | 0.21% | 60 |
|
|
2013
Q3 | $5.74M | Buy |
91,542
+2,052
| +2% | +$129K | 1.45% | 34 |
|
|
2013
Q2 | $5.59M | Buy |
+89,490
| New | +$5.59M | 1.49% | 32 |
|